COVID-19
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyBioResearch
Events
- Angiopoietin-Like 2 Is a Biomarker for Diabetic Foot Patients
- Gestational Lipid Profiles Associated with Adverse Cardiovascular Risk
- Novel Biomarkers Predict the Development of Incident Heart Failure
- Hyperglycemia and Hypoglycemia Associated with Poor Outcomes in COVID-19 Patients
- Novel Biomarker Candidate for Amyotrophic Lateral Sclerosis Explored
- Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles
- Common Brain Malformation Traced to Its Genetic Roots
- Predicting Thrombosis Risk in SLE Patients by Monitoring Blood Levels of Hydroxychloroquine
- Elevated Galectin-1 Levels in Sepsis Reflect Danger of Cytokine Storm Development
- Next Generation Sequencing Developed for Monitoring of Mixed Chimerism
- Coagulopathy Testing Linked to Better COVID-19 Outcomes
- Preterm Infants Tolerate Restrictive Red Blood Cell Transfusion Strategy
- Automated Hematologic Reference Intervals Defined for Newborns
- Blood Type Linked to Risk of COVID-19 Infection Severity
- Chronic Lymphocytic Leukemia Increases Peripheral Blood Hematopoietic Stem Cells
- Combination Urinary Biomarker Panel Detects Pancreatic Cancer Earlier
- Preliminary Predictive Criteria Identified for COVID-19 Cytokine Storm
- Osteopontin Linked to Progressive Lung Scarring in Scleroderma Patients
- Newly Developed Immunoassay Evaluated for Infectious Diseases
- Biomarker Evaluated for Early Detection of Congenital Heart Disease
- Immunohistological Detection of Small Particles of Echinococcus Species Evaluated
- MALDI-TOF-MS Evaluated for Rapid Diagnosis of Bacteremia and Fungemia
- Scrub Typhus Enzyme Linked Immunoassay Evaluated for Accuracy
- Quick Ultra-Sensitive System Identifies Multidrug-Resistant Bacteria
- MALDI-TOF MS Employed for Early Diagnosis of Bloodstream Infections
- Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech
- Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer
- PerkinElmer to Acquire Oxford Immunotec Global PLC
- YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology
- Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Metastatic Gastric Cancer Outcomes Informed by Single-Cell Transcriptome Profiles
- Multiplex Bead-Based Immunoassay Validated for Non-Invasive Bladder Cancer Detection
- Rare Genetic Variants Can Contribute to Ischemic Heart Failure
- Circulating Tumor Cell Dynamics Predicts Cancer Prognosis
- Mitoses Counted with Digital Pathology in Breast Phyllodes Tumors
COVID-19
- Angiopoietin-Like 2 Is a Biomarker for Diabetic Foot Patients
- Gestational Lipid Profiles Associated with Adverse Cardiovascular Risk
- Novel Biomarkers Predict the Development of Incident Heart Failure
- Hyperglycemia and Hypoglycemia Associated with Poor Outcomes in COVID-19 Patients
- Novel Biomarker Candidate for Amyotrophic Lateral Sclerosis Explored
- Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles
- Common Brain Malformation Traced to Its Genetic Roots
- Predicting Thrombosis Risk in SLE Patients by Monitoring Blood Levels of Hydroxychloroquine
- Elevated Galectin-1 Levels in Sepsis Reflect Danger of Cytokine Storm Development
- Next Generation Sequencing Developed for Monitoring of Mixed Chimerism
- Coagulopathy Testing Linked to Better COVID-19 Outcomes
- Preterm Infants Tolerate Restrictive Red Blood Cell Transfusion Strategy
- Automated Hematologic Reference Intervals Defined for Newborns
- Blood Type Linked to Risk of COVID-19 Infection Severity
- Chronic Lymphocytic Leukemia Increases Peripheral Blood Hematopoietic Stem Cells
- Combination Urinary Biomarker Panel Detects Pancreatic Cancer Earlier
- Preliminary Predictive Criteria Identified for COVID-19 Cytokine Storm
- Osteopontin Linked to Progressive Lung Scarring in Scleroderma Patients
- Newly Developed Immunoassay Evaluated for Infectious Diseases
- Biomarker Evaluated for Early Detection of Congenital Heart Disease
- Immunohistological Detection of Small Particles of Echinococcus Species Evaluated
- MALDI-TOF-MS Evaluated for Rapid Diagnosis of Bacteremia and Fungemia
- Scrub Typhus Enzyme Linked Immunoassay Evaluated for Accuracy
- Quick Ultra-Sensitive System Identifies Multidrug-Resistant Bacteria
- MALDI-TOF MS Employed for Early Diagnosis of Bloodstream Infections
- Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech
- Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer
- PerkinElmer to Acquire Oxford Immunotec Global PLC
- YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology
- Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Procter & Gamble’s Novel Fully Injection-Molded Polypropylene Nasal Swab Improves Speed of COVID-19 Testing
- Daily Rapid Lateral Flow COVID-19 Tests for Traced Contacts for Five Days Could Replace Requirement to Quarantine, Reveals Study
- New AI-Driven COVID-19 Testing Algorithm Could Lead to Fewer Infections
- Innovative Pain-Free Microneedle Patch with Unprecedented Sensitivity Can Test for Level of Antibodies Against COVID-19
- COVID-19 Testing Demand to Help In-Vitro Diagnostics (IVD) Market Reach USD 118.5 Billion by 2027
- Metastatic Gastric Cancer Outcomes Informed by Single-Cell Transcriptome Profiles
- Multiplex Bead-Based Immunoassay Validated for Non-Invasive Bladder Cancer Detection
- Rare Genetic Variants Can Contribute to Ischemic Heart Failure
- Circulating Tumor Cell Dynamics Predicts Cancer Prognosis
- Mitoses Counted with Digital Pathology in Breast Phyllodes Tumors
Client Login